Nanjing Vishee Medical Technology Co., Ltd (SHA:688580)

SHA:688580 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	478.71	462.73	400.06	462.22	321.62	430.04
Revenue Growth	14.27%	15.66%	-13.45%	43.72%	-25.21%	13.66%
Gross Profit Gross Profit Growth	316.83	305.84	261.8	313.06	233.1	321.59
Operating Income Operating Income Growth	137.74	131.98	82.48	114.75	66.82	148.07
Net Income Net Income Growth	168.87	138.07	101.97	136.26	93.83	177.81
Earnings Per Share EPS Growth	1.77	1.44	1.07	1.42	0.98	1.85
EPS Growth	39.24%	34.58%	-24.84%	45.16%	-47.07%	5.42%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025
Period Ending	Jun 30, 2026	Dec 31, 2025
Magnetic Stimulation Magnetic Stimulation Growth	205.05	189.33
Electrophysiology Electrophysiology Growth	78.94	88.94
Consumables and Accessories Consumables and Accessories Growth	86.13	84.12
Laser RF Class Laser RF Class Growth	53.43	45.71
Electrical Stimulation Electrical Stimulation Growth	39.78	38.87
Others Others Growth	14.37	15.76
Total Total Growth	477.71	462.73

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	859.61	1,023	1,068	1,155	1,248	1,366
Total Debt Total Debt Growth	0.37	1.05	1.65	-	1.19	2.99
Net Cash (Debt) Net Cash Growth	859.24	1,022	1,067	1,155	1,247	1,363
Net Cash Growth	-14.60%	-4.18%	-7.66%	-7.37%	-8.52%	-0.25%
Net Cash Per Share Net Cash Per Share Growth	9.00	10.66	11.19	12.07	13.03	14.20

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	171.22	176.74	118.29	134.2	86.17	157.37
Capital Expenditures CapEx Growth	-154.41	-118.12	-113.08	-133.48	-95.61	-87.34
Free Cash Flow Free Cash Flow Growth	16.81	58.63	5.21	0.72	-9.45	70.02
Free Cash Flow Growth	-63.94%	1024.89%	627.46%	-	-	-35.82%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	66.19%	66.09%	65.44%	67.73%	72.48%	74.78%
Operating Margin	28.77%	28.52%	20.62%	24.82%	20.77%	34.43%
Pretax Margin	40.15%	33.37%	28.32%	32.45%	32.91%	45.90%
Profit Margin	35.28%	29.84%	25.49%	29.48%	29.17%	41.35%
FCF Margin	3.51%	12.67%	1.30%	0.15%	-2.94%	16.28%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.108	0.108	0.800	1.076	0.491	0.930
Dividend Per Share Growth	35.25%	-86.48%	-25.62%	119.02%	-47.19%	23.87%
Dividend Yield	0.25%	0.23%	2.98%	2.53%	1.40%	1.33%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	24.07	33.55	26.01	32.01	38.91	41.82
Forward PE	24.48	30.38	15.10	23.98	20.71	32.77
P/FCF Ratio	242.50	79.02	508.83	6087.76	-	106.20
PS Ratio	8.52	10.01	6.63	9.44	11.35	17.29

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 26, 2026

Data Sources Report a data error